Martin Werner Hümmert

13PUBLICATIONS
84CO-AUTHORS
AutoimmunityOptical technologyPacific Peoples and disabilityNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 23, 2026
MOG Antibody Status Is Associated With Distinct Clinical Profiles and Treatment Responses in Chronic Relapsing Inflammatory Optic Neuropathy.

|Jul 02, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

|Oct 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Anna Walz, Daria Tkachenko, Martin W Hümmert

|Jun 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom.

Daniel Engels, Chiara Rocchi, Mirasol Forcadela

|Dec 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Vivien Häußler, Corinna Trebst, Daniel Engels

|Nov 04, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.

Carolin Schwake, Theodoros Ladopoulos, Vivien Häußler

Pageof 3

Frequent Collaborators

8 joint publications

Vivien Häußler

8 joint publications

Joachim Havla

7 joint publications

Marius Ringelstein

6 joint publications

Tania Kümpfel